Search results for "LEASING"

showing 10 items of 140 documents

Hormonal responsiveness in the Trier Social Stress Test and the dexamethasone‐corticotropin releasing hormone test in healthy individuals

2021

A number of different laboratory procedures investigate the hormonal response in a standardized pharmacological challenge test (dexamethasone-corticotropin releasing hormone; DEX-CRH) or in a psychosocial stress induction on the hypothalamic-pituitary-adrenocortical axis by the Trier Social Stress Test (TSST). However, the magnitude of the response related to the different stressors and the interaction of the responsiveness between the two tests is still unclear. Fifty-two participants underwent both the DEX-CRH test and the TSST on two separate days. The cortisol and the plasma adrenocorticotropic hormone (ACTH) release were assessed before and after the stress tests. For a specification o…

endocrine systemmedicine.medical_specialtyHydrocortisoneCorticotropin-Releasing HormoneAdrenocorticotropic hormoneDexamethasone03 medical and health sciencesCorticotropin-releasing hormone0302 clinical medicineAdrenocorticotropic HormoneInternal medicinepolycyclic compoundsmedicineTrier social stress testHumansGeneral PsychologyDexamethasonePsychological Testsbusiness.industryStressor030227 psychiatryTest (assessment)EndocrinologyHealthy individualsbusinesshormones hormone substitutes and hormone antagonists030217 neurology & neurosurgerymedicine.drugHormonePsyCh Journal
researchProduct

Transgenic overexpression of corticotropin releasing hormone provides partial protection against neurodegeneration in an in vivo model of acute excit…

2008

Abstract Corticotropin releasing hormone (CRH) is the central modulator of the mammalian hypothalamic–pituitary–adrenal (HPA) axis. In addition, CRH affects other processes in the brain including learning, memory, and synaptic plasticity. Moreover, CRH has been shown to play a role in nerve cell survival under apoptotic conditions and to serve as an endogenous neuroprotectant in vitro . Employing mice overexpressing murine CRH in the CNS, we observed a differential response of CRH-overexpressing mice (CRH-COE hom -Nes) to acute excitotoxic stress induced by kainate compared with controls (CRH-COE con -Nes). Interestingly, CRH-overexpression reduced the duration of epileptic seizures and pre…

endocrine systemmedicine.medical_specialtyIndolesRNA UntranslatedCorticotropin-Releasing HormoneExcitotoxicityMice TransgenicNerve Tissue ProteinsBiologymedicine.disease_causeNeuroprotectionHippocampusNestinCorticotropin-releasing hormoneMiceIntermediate Filament ProteinsNeurotrophic factorsNeurofilament ProteinsSeizuresInternal medicineGlial Fibrillary Acidic Proteinpolycyclic compoundsmedicineExcitatory Amino Acid AgonistsReaction TimeAnimalsNeuroinflammationBrain-derived neurotrophic factorAnalysis of VarianceKainic AcidCell DeathGeneral NeuroscienceBrain-Derived Neurotrophic FactorNeurodegenerationProteinsLong-term potentiationmedicine.diseaseDisease Models AnimalEndocrinologynervous systemGene Expression RegulationNerve DegenerationNeurotoxicity SyndromesPlant Lectinshormones hormone substitutes and hormone antagonistsNeuroscience
researchProduct

Binding of Cu2+, Zn2+, and Ni(2+)-GnRH complexes with the rat pituitary receptor.

1997

Complex of copper with the gonadotropin-releasing hormone, GnRH, competed more efficiently for the GnRH receptor than native GVRH, while complexes of nickel with GnRH and zinc with GnRH had slightly lower affinity. Copper ion added to the incubation mixture inhibited the buserelin binding to the receptor.

endocrine systemmedicine.medical_specialtyKineticschemistry.chemical_elementGonadotropin-releasing hormoneZincBiochemistryBinding CompetitiveBuserelinInorganic ChemistryGonadotropin-Releasing HormoneNickelPituitary Gland AnteriorInternal medicinemedicineAnimalsReceptorIncubationChemistryCopperBuserelinRatsKineticsZincEndocrinologyhormones hormone substitutes and hormone antagonistsCopperReceptors LHRHmedicine.drugHormoneJournal of inorganic biochemistry
researchProduct

Human Oviductal Gonadotropin-Releasing Hormone: Possible Implications in Fertilization, Early Embryonic Development, and Implantation1

2000

The oviduct is host to gametes and early embryos at a critical point in their lives. It is clear that the interactions of gametes/early embryo with the maternal oviduct in an autocrine and paracrine manner provide a microenvironment that enhances fertilization, early embryonic development, and implantation. Moreover, there is considerable evidence that an extrahypothalamic GnRH may play a substantial role as a molecular autocrine/paracrine regulator in these events. Gametes and preimplantation embryos express GnRH and GnRH receptor at both messenger ribonucleic acid (mRNA) and protein levels. However, whether GnRH is produced by the human oviduct has not yet been demonstrated. We used RT-PC…

endocrine systemmedicine.medical_specialtyanimal structuresurogenital systemEndocrinology Diabetes and MetabolismBiochemistry (medical)Clinical BiochemistryEmbryogenesisEmbryoGonadotropin-releasing hormoneBiologyLuteal phaseBiochemistryParacrine signallingEndocrinologyHuman fertilizationEndocrinologyInternal medicinemedicineOviductAutocrine signallinghormones hormone substitutes and hormone antagonistsThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Respiratory Parameters after Systemic Corticotropin-Releasing Hormone Administration

1991

Neuroanatomical studies on the distribution of corticotropin-releasing hormone (CRH) and its receptors (7) as well as physiological data suggest a regulatory function of endogenous CRH in hypothalamic and extrahypothalamic brain areas [1, 4]. Endogenous CRH acts within the endocrine hypothalamo-pituitary-adrenal axis and affects cardiovascular regulation and respiration through extrahypothalamic pathways. CRH also stimulates gluconeogenesis and release of plasma-catecholamines. Our experiments in humans also demonstrate an influence on respiration and on heart rate activity after systemic application of CRH. Respiratory parameters and heart rate were analyzed during steady-state conditions …

endocrine systemmedicine.medical_specialtybusiness.industryEndogenyCorticotropin-releasing hormoneEndocrinologynervous systemInternal medicineHeart ratepolycyclic compoundsmedicineEndocrine systemRespiratory systembusinessReceptorhormones hormone substitutes and hormone antagonistsRespiratory minute volumeHormone
researchProduct

Extrapituitary Effects of Corticotropin Releasing Hormone and Thyrotropin Releasing Hormone

1993

Besides their regulation of the pituitary-adrenal and pituitary-thyroidal axis, respectively, the neurohormones CRH and TRH act within the central nervous system to evoke and modulate a number of behavioral and physiological processes. In particular, an increase in the sympathetic nervous system and respiratory activity has been observed. The data communicated in this review article emphasize the role of these neurohormones with regard to the neuroendocrine regulation of the autonomic nervous system, sleep and cognitive performance. Moreover, a possible therapeutic role is suggested by the beneficial effects in patients at risk of hypoventilation-associated disorders.

endocrine systemmedicine.medical_specialtyendocrine system diseasesCorticotropin-Releasing HormoneCentral nervous systemThyrotropin-releasing hormoneCardiovascular Physiological PhenomenaPsychiatry and Mental healthCorticotropin-releasing hormoneNeuropsychology and Physiological PsychologyEndocrinologymedicine.anatomical_structureInternal medicineRespiratory Physiological PhenomenamedicineAnimalsHumansPsychologyNeurohormonesThyrotropin-Releasing Hormonehormones hormone substitutes and hormone antagonistsBiological PsychiatryNeuropsychobiology
researchProduct

Increased LH and FSH release from the anterior pituitary of ovariectomized rat, in vivo, by copper-, nickel-, and zinc-LHRH complexes.

1992

Abstract The effect of Cu 2+ , Ni 2+ , Zn 2+ and their complexes with LHRH on the release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) was estimated in in vivo experiments with the use of the method proposed by Ramirez and McCann. Ovariectomized, estradiol, and progesterone pretreated rats were injected intraveneously either with LHRH alone, a metal ion alone, a mixture of metal and hormone, or a metal-LHRH complex. A metal alone or a mixture of it with LHRH did not affect gonadotropin release at all or no more than LHRH alone. However, the complex of Cu 2+ with LHRH brought about a high release of LH and even higher release of FSH. This indicates that copper complex i…

endocrine systemmedicine.medical_specialtymedicine.drug_classOvariectomyPeptide hormoneBiochemistryInorganic ChemistryGonadotropin-Releasing HormoneFollicle-stimulating hormoneAnterior pituitaryIn vivoNickelPituitary Gland AnteriorInternal medicinemedicineAnimalsProgesteroneEstradiolChemistryRats Inbred StrainsLuteinizing HormoneRatsZincmedicine.anatomical_structureEndocrinologyMetalsOvariectomized ratFemaleGonadotropinFollicle Stimulating HormoneLuteinizing hormonehormones hormone substitutes and hormone antagonistsCopperHormoneJournal of inorganic biochemistry
researchProduct

Thyrotrophin-releasing hormone-a lactation-promoting agent?

1991

Objective— To study the lactational and hormonal responses to nasal administration of thyrotrophin-releasing hormone (TRH) in puerperal women with inadequate lactation. Design— Prospective randomized double-blind placebo-controlled study. Subjects— 19 puerperal women with inadequate lactation (<50% of normal milk yield) on the 5th day postpartum. Interventions— 10 women were allocated to receive TRH administered by a nasal spray of 1 mg, four times daily, between suckling episodes, for 10 consecutive days starting on day 6 postpartum. Nine women were allocated to receive placebo sprays. Main outcome measures— Daily milk yield, serum levels of prolactin and thyroid hormones. Results— Before …

endocrine systemmedicine.medical_specialtymedicine.medical_treatmentThyrotropinLactation DisordersPeptide hormonePlaceboDrug Administration ScheduleDouble-Blind MethodThyroid-stimulating hormoneLactationInternal medicinemedicineHumansProspective StudiesThyrotropin-Releasing HormoneAdministration IntranasalTriiodothyroninebusiness.industryObstetrics and GynecologyProlactinProlactinThyroxinemedicine.anatomical_structureEndocrinologyNasal sprayTriiodothyronineFemalebusinesshormones hormone substitutes and hormone antagonistsHormoneBJOG: An International Journal of Obstetrics and Gynaecology
researchProduct

Effect of Cetrorelix on sperm morphology during migration through the epididymis in the cynomolgus macaque (Macaca fascicularis)

2000

The importance of the cynomolgus monkey as a model for human reproductive medicine prompted this examination of epididymal sperm morphology. Computer-aided sperm morphological analysis was used for the first time to provide morphometric data on sperm heads as they traversed the epididymal duct of Macaca fascicularis. The duct was divided into six regions, starting close to the testis (proximal) and ending close to the vas deferens (distal). To determine the androgen-dependence of the changes, one group of animals received a GnRH-antagonist (Cetrorelix, Asta Medica, Frankfurt, Germany) to induce testicular regression and lower epididymal androgens, while a control group received only vehicle…

endocrine systemurogenital systemmedicine.drug_classVas deferensSemenAnatomyGonadotropin-releasing hormoneBiologyAndrogenEpididymisSpermmedicine.anatomical_structuremedicineAnimal Science and ZoologyTesticular RegressionEcology Evolution Behavior and SystematicsSperm motilityAmerican Journal of Primatology
researchProduct

Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women.

2022

Total hysterectomy and bilateral adnexectomy is the standard treatment for atypical endometrial hyperplasia and early-stage endometrial cancer. However, the recommended surgical treatment precludes future pregnancy when these conditions are diagnosed in women in their fertile age. In these patients, fertility-sparing treatment may be feasible if the desire for childbearing is consistent and specific conditions are present. This review summarizes the available evidence on fertility-sparing management for atypical endometrial hyperplasia and early-stage endometrial cancer. Historically, oral progestins have been the mainstay of conservative management for atypical endometrial hyperplasia and …

fertility-sparing treatmentFertility PreservationGeneral MedicineConservative TreatmentSettore MED/40 - Ginecologia E OstetriciaMetforminEndometrial NeoplasmsProgestinGonadotropin-Releasing HormoneTreatment OutcomeRetrospective StudiePregnancyendometrial cancerEndometrial HyperplasiaHumansEndometrial NeoplasmFemaleendometrial atypical hyperplasiaProgestinsHumanRetrospective StudiesMedicina (Kaunas, Lithuania)
researchProduct